Editorial Policy.

CANCER GENOMICS & PROTEOMICS (CGP) welcomes the submission of original high quality articles and reviews on the application of genomic and proteomic technology to basic, experimental and clinical cancer research. The journal's topical spectrum includes:(a) Molecular causes of carcinogenesis, cancer progression and metastasis; (b) Structural and functional aspects of genes in the cancer cell; (c) Advances in genomic and proteomic technologies applicable to cancer research; (d) Rational anticancer drug design and drug development.

CGP will also accept abstracts and proceedings of scientific meetings for publication, following consideration and approval by the Editorial Board.

The principal aim of CGP is to provide for the prompt publication of original works of high quality, generally within 1-2 months of final acceptance. Manuscripts will be accepted with the understanding that they report original unpublished works that are not under consideration for publication by another journal, and that they will not be published again in the same form. All material submitted to CGP will be subject to review, by two members of the Editorial Board and by one suitable outside referee. All manuscripts submitted to CGP are treated in confidence, without access to any person other that the Editor-in-Chief, the Managing Editor, the journal's secretary, the reviewers and the printers. The Editors reserve the right to improve manuscripts on grammar and style.

Copyright.
Once a manuscript has been published in CGP, which is a copyrighted publication, the legal ownership of all published parts of the paper has passed from the Author(s)to the journal. Material published in the journal may not be reproduced or published elsewhere without written consent of the Managing Editor.

Format.
Two types of papers may be submitted:(i)Full papers containing completed original work, and (ii)Review articles concerning fields of recognizable progress. Papers should contain all essential data in order to make the presentation clear. Papers should be written in clear, concise English. Spelling should follow that given in the" Shorter Oxford English Dictionary".

Manuscripts.
Submitted manuscripts should not exceed fourteen (14)pages (approximately 250 words per double -spaced typed page), including abstract, text, tables, figures, and references (corresponding to 4 printed pages). Papers exceeding four printed pages will be subject to excess page charges. All manuscripts should be divided into the following sections:(a)First page including the title of the presented work [not exceeding fifteen (15)words ], full names and full postal addresses of all Authors, name of the Author to whom proofs are to be sent, key words, an abbreviated running title and the date of submission. (Note:The order of the Authors is not necessarily indicative of their contribution to the work. Authors may note their individual contribution(s)in the appropriate section(s)of the presented work);(b)Abstract not exceeding 200 words, organized according to the following headings:Background -Materials and Methods -Results -Conclusions; (c)Introduction; (d)Materials and Methods, or Patients and Methods; (e)Results; (f)Discussion; (g)Acknowledgements, and (h)References. All pages must be numbered consecutively. Footnotes should be avoided. Review articles may follow a different style according to the subject matter and the Author's opinion. Review articles should not exceed 35 pages (approximately 250 words per double-spaced typed page)including all tables, figures, and references.

Figures.
All figures (whether photographs or graphs)should be clear, high contrast, glossy prints of the size they are to appear in the journal:8 00 cm (3.15 in.) wide for a single column;17.00 cm (6.70 in.) for a double column; maximum height:20.00 cm (7.87 in.). Graphs must be submitted as photographs made from drawings and must not require any artwork, typesetting, or size modifications. Symbols, numbering and lettering should be clearly legible. The number and top of each figure must be indicated on the reverse side. Original karyotypes and photographs should be provided wherever possible, and not photographic copies. A charge will be made for a colour plate.

Tables.
Each table should be submitted on a separate page, typed double-spaced. Tables should be numbered with Roman numerals and should include a short title.


References.

Authors must assume responsibility for the accuracy of the references used. In the text, references should be cited by number. Citations for the reference section of submitted works must be numbered in the order they appear. Examples:1 Sumner AT:The nature of chromosome bands and their significance for cancer research. Anticancer Res 1:205-216, 1981. 2. McGuire WL and Chamnesss GC:Studies on the oestrogen receptor in breast cancer. In :Receptors for reproductive hormones
(O Õ Malley BW and Chamnes GC, , eds). New York, Plenum Publ Corp, 1973, pp. 133-136.

Nomenclature and Abbreviations.
Nomenclature should follow that given in "Chemical Abstracts", "Index Medicus"," Merck Index", "IUPAC - IUB", "Bergey's Manual of Determinative Bacteriology". The CBE Manual for Authors, Editors and Publishers (6th edition, 1994), MIAME Standard for Microarray Data. Human gene symbols may be obtained from HUGO Gene Nomenclature Committee (HGNC) (http://www. gene.ucl.ac.uk/). Approved mouse nomenclature may be obtained from http://www. informatics. jax. org/. Standard abbreviations will be preferable. If a new abbreviation is used it must be defined at its first usage.

Ethical Policies and Standards.
CGP agrees with and follows the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals"established by the International Committee of Medical Journal Editors in 1978 and updated October 2001 (www.icmje.org). Microarray data analysis should comply with the "Minimum Information About Microarray Experiments (MIAME) standard". Specific guidelines are provided at the "Microarray Gene Expression Data Society (MGED)website. Presentation of genome sequences should follow the guidelines of the NHGRI Policy on Release of Human Genomic Sequence Data. Research involving human beings must adhere to the principles of the Declaration of Helsinki and Title 45, U. S. Code of Federal Regulations, Part 46, Protection of Human Subjects, effective December 13, 2001. Research involving animals must adhere to the Guiding Principles in the Care and Use of Animals approved by the Council of the American Physiological Society. The use of animals in biomedical research should be under the careful supervision of a person adequately trained in this field and at all times the animals must be treated humanely. Research involving the use of human fetuses, fetal tissue, embryos and embryonic cells should adhere to the U. S. Public Law 103-41, effective December 13, 2001.

Submission of Manuscripts.
An original and two copies of the manuscript (including all photographs and graphs) should be submitted. Manuscripts from North America may be sent to the Editor-in-Chief or to the Managing Editor. Manuscripts from the rest of the world should be sent to the Managing Editor. Addresses:Editor-in-Chief, CGP, Prof. A. Seth, Laboratory of Molecular Pathology, Sunnybrook and Women's College Health Sciences Center, University of Toronto, 2075 Bayview Avenue, Toronto, Ont. , Canada M4N 3M5;Managing Editor, Dr J. G. Delinassios, Cancer Genomics and Proteomics, International Institute of Anticancer Research, 1st km Kapandritiou-Kalamou Rd. , Kapandriti, P. O. B. 22, Attiki 19014, Greece.
A floppy disc, CD-ROM or ZIP-disc must also be submitted indicating the computer-processing program. Authors are invited to submit along with their manuscripts a short list of possible reviewers and any previous publications which could facilitate reviewing. Manuscripts should be accompanied by six adhesive labels with the name and address of the Author to whom correspondence should be sent. Only the original copy of the submitted manuscript will be returned to Authors upon rejection.
Manuscripts may also be submitted electronically to: editor@cgp-journal.com

Galley Proofs.
Unless otherwise indicated, galley proofs will be sent by e-mail to the first-named Author of the submission. Corrections of galley proofs should be limited to typographical errors.Reprints. Twenty-five copies of each communication will be provided free of charge. Additional copies may be ordered after the acceptance of the paper. Requests for additional reprints should be addressed to the Editorial Office.Galley Proofs. Unless otherwise indicated, galley proofs will be sent by e-mail to the first-named Author of the submission. Corrections of galley proofs should be limited to typographical errors.

Reprints.
Twenty-five copies of each communication will be provided free of charge. Additional copies may be ordered after the acceptance of the paper. Requests for additional reprints should be addressed to the Editorial Office.

 
 
 
 
           
Copyright © 2007 Cancer Genomics & Proteomics. All rights reserved